Long-Term Study of Safety and Efficacy of WelChol® as an Additional Therapy in Patients With Type 2 Diabetes

NCT00151762 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

780

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Colesevelam hydrochloride

Sponsor

Daiichi Sankyo